AU2021266603A1 - Stem cells for treatment of respiratory disorders - Google Patents

Stem cells for treatment of respiratory disorders Download PDF

Info

Publication number
AU2021266603A1
AU2021266603A1 AU2021266603A AU2021266603A AU2021266603A1 AU 2021266603 A1 AU2021266603 A1 AU 2021266603A1 AU 2021266603 A AU2021266603 A AU 2021266603A AU 2021266603 A AU2021266603 A AU 2021266603A AU 2021266603 A1 AU2021266603 A1 AU 2021266603A1
Authority
AU
Australia
Prior art keywords
composition
mscs
use according
disease
integrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021266603A
Other languages
English (en)
Inventor
Sandra LINDSTEDT
Åkerlund Evy Lundgren
Tania RAMOS MORENO
Christina UVEBRANT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xintela AB
Original Assignee
Xintela AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xintela AB filed Critical Xintela AB
Publication of AU2021266603A1 publication Critical patent/AU2021266603A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transplantation (AREA)
AU2021266603A 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders Pending AU2021266603A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20173592 2020-05-07
EP20173592.5 2020-05-07
PCT/EP2021/062111 WO2021224449A1 (en) 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders

Publications (1)

Publication Number Publication Date
AU2021266603A1 true AU2021266603A1 (en) 2022-12-08

Family

ID=70738255

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2021266603A Pending AU2021266603A1 (en) 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders

Country Status (11)

Country Link
US (1) US20230346843A1 (https=)
EP (1) EP4146234A1 (https=)
JP (1) JP7821414B2 (https=)
KR (1) KR20230008159A (https=)
CN (1) CN116018149A (https=)
AU (1) AU2021266603A1 (https=)
BR (1) BR112022022355A2 (https=)
CA (1) CA3177704A1 (https=)
IL (1) IL297902A (https=)
MX (1) MX2022013939A (https=)
WO (1) WO2021224449A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202103890D0 (en) * 2021-03-19 2021-05-05 Amniotics Ab Stem cells for use in reducing the immune response following organ transplantation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099337A1 (en) * 2006-03-01 2007-09-07 Cartela R&D Ab Expansion and differentiation of mesenchymal stem cells
CN110177560A (zh) * 2016-12-28 2019-08-27 智再如股份有限公司 活体组织损伤的修复剂以及该修复剂的制造方法
ES2870776T3 (es) 2017-01-27 2021-10-27 Xintela Ab Prevención y tratamiento de daños o enfermedades de los huesos y cartílagos
CN116590227A (zh) * 2017-03-03 2023-08-15 日本乐敦制药株式会社 间充质干细胞和肝疾病治疗剂
WO2018159432A1 (ja) * 2017-03-03 2018-09-07 ロート製薬株式会社 間葉系幹細胞及び医薬組成物

Also Published As

Publication number Publication date
CN116018149A (zh) 2023-04-25
BR112022022355A2 (pt) 2022-12-13
JP2023524150A (ja) 2023-06-08
MX2022013939A (es) 2023-02-09
CA3177704A1 (en) 2021-11-11
US20230346843A1 (en) 2023-11-02
JP7821414B2 (ja) 2026-02-27
EP4146234A1 (en) 2023-03-15
KR20230008159A (ko) 2023-01-13
WO2021224449A1 (en) 2021-11-11
IL297902A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
Lu et al. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury
JP7691488B2 (ja) 肺疾患を治療するための方法及び組成物
CN106714781B (zh) 涉及外排体的方法和组合物
Chou et al. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia
JP2020531011A (ja) 精製された間葉系幹細胞エキソソームおよびその使用
EP3443966A1 (en) Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
CN105338989A (zh) 改进用于移植的器官
KR102464099B1 (ko) 다능성 간세포에 의한 허혈재관류 폐장애의 경감 및 치료
Möbius et al. Prophylactic administration of mesenchymal stromal cells does not prevent arrested lung development in extremely premature-born non-human primates
Chaleshtori et al. Prevention of LPS-induced acute respiratory distress syndrome in sheep by bone marrow-derived mesenchymal stem/stromal cells
Li et al. Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis
JP7821414B2 (ja) 呼吸器疾患治療のための幹細胞
Siavashi et al. The improvement of respiratory performance after phototherapy‐induced EPC mobilization in preterm infants with RDS
WO2014089397A1 (en) Compositions and methods of treating and preventing pulmonary fibrosis
CN117425724A (zh) 肿瘤缺氧驯化的再生巨噬细胞的获得方法及其在再生医学中的用途
US20200054684A1 (en) Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
US20230338432A1 (en) Methods and compositions for treating viral infections and sequelae thereof
Tran et al. The synergistic effects of mechanical ventilation and intrauterine inflammation on cerebral inflammation in preterm fetal sheep
Wu et al. Wnt3a Enhances Mesenchymal Stem Cell Engraftment and Differentiation in a Chronic Obstructive Pulmonary Disease Rat Model
Jerzak et al. Diffuse alveolar haemorrhage--case report and literature review.
Hoang Stem Cell Therapy for Treatment of Bronchopulmonary Dysplasia
US20180353549A1 (en) Compositions and method for treating and preventing bleeding and lung injuries and diseases
Curley Investigation of the mechanisms of repair following Ventilator Induced Lung Injury and the potential for Mesenchymal Stem Cells to enhance the repair process
Horie Therapies for acute respiratory distress syndrome: determination of the mechanisms of action of hypercapnia and the therapeutic efficacy of mesenchymal stromal cells
Spaziano et al. Research Article New Role of Adult Lung c-kit Cells in a Mouse Model of Airway Hyperresponsiveness